They could be in the pricing period for a horrendously dilutive financing. That would fit in with the CEOs delusional approach to running the company - 'Partners? We don't need no partners, we're the next Amgen'. Good luck trying to raise money at .08 cents Nic.
Congratulations Nic, you managed to sabotage one of the world's most promising new technologies.